63844 Federal Register / Vol. 75, No. 200 / Monday, October 18, 2010 / Notices 

Diabetes and Digestive and Kidney 

Diseases Special Emphasis Panel, 

October 13, 2010, 7 p.m. to October 14, 

2010, 5 p.m., Radisson National Airport, 

2020 Jefferson Davis Highway, 

Arlington, VA 22202 which was 

published in the Federal Register on 

September 16, 2010, 179 FR 56551. 

The meeting location has changed. 

The meeting will be held at the Hilton 

Crystal City at Washington Reagan 

National Airport, 2399 Jefferson Davis 

Highway in Arlington, VA 22202. The 

meeting is closed to the public. 

Dated: October 7, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26183 Filed 10–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Toxicology Training Using 

Systems-Based Technology. 

Date: November 1, 2010. 

Time: 2:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Research 

Triangle Park, NC 27709. 

Contact Person: Leroy Worth, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research and 

Training, Nat. Institute of Environmental 

Health Sciences, P. O. Box 12233, MD EC– 

30/Room 3171, Research Triangle Park, NC 

27709, (919) 541–0670, worth@niehs.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: October 8, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26192 Filed 10–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Health Resources and Services 

Administration CDC/HRSA Advisory 

Committee on HIV and STD Prevention 

and Treatment (CHACHSPT) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), CDC/HRSA announces 

the following meeting of the 

aforementioned committee: 

Times and Dates: 

8 a.m.–5:30 p.m., November 15, 2010. 

8 a.m.–3 p.m., November 16, 2010. 

Place: Omni Shoreham Hotel, 2500 Calvert 

Street, NW., (at Connecticut Avenue) 

Washington, DC 20008. Telephone: (202) 

234–0700. 

Status: Open to the public, limited only by 

the space available. The meeting room will 

accommodate approximately 100 people. 

Purpose: This Committee is charged with 

advising the Director, CDC, and the 

Administrator, HRSA, regarding activities 

related to prevention and control of HIV/ 

AIDS and other STDs; the support of health 

care services to persons living with HIV/ 

AIDS; and the education of health 

professionals and the public about HIV/AIDS 

and other STDs. 

Matters To Be Discussed: Agenda items 

include issues regarding: (1) HHS 

coordination and implementation of the 

National HIV/AIDS Strategy; (2) CHACHSPT 

Realignment Program Review Workgroup 

update; (3) update on strategies to educate 

the medical community on the need to 

routinely offer HIV testing to females, older 

persons, and other patients determined to be 

at low risk; and (4) updates on HIV 

prevention research and program 

implementation. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Margie Scott-Cseh, CDC, National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention, 1600 Clifton Road, NE., Mailstop 

E–07, Atlanta, Georgia 30333, Telephone 

(404) 639–8317. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 8, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–26144 Filed 10–15–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC announces 

the following meeting of the 

aforementioned committee: 

Times and Dates: 

9 a.m.–5 p.m., November 4, 2010. 

9 a.m.–12 p.m., November 5, 2010. 

Place: Washington Marriott at Metro 

Center, Salons C–D, 775 12th Street, 

NW., Washington, DC 20005 

Status: This meeting is open to the 

public, limited only by the space 

available. Please register for the meeting 

online at http://www.cdc.gov/hicpac or 

by sending an e-mail to hicpac@cdc.gov. 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Secretary, the Assistant Secretary for 

Health, the Director, CDC, and the 

Director, National Center for Emerging 

and Zoonotic Infectious Diseases 

(NCEZID), regarding the practice of 

healthcare infection control and 

strategies for surveillance, prevention, 

and control of healthcare-associated 

infections (e.g., nosocomial infections), 

antimicrobial resistance, and related 

events in settings where healthcare is 

provided, including hospitals, 

ambulatory and long-term care facilities, 

and home health agencies. The 

Committee shall advise CDC on periodic 

updating of guidelines and other policy 

statements regarding prevention of 

healthcare-associated infections and 

healthcare-related conditions. 

Matters To Be Discussed: The agenda 

will include updates on CDC’s activities 

for healthcare-associated infections; the 

draft guideline for the Prevention of 

Norovirus Gastroenteritis Outbreaks in 

Healthcare Settings; draft guideline for 

prevention of infections among patients 

in neonatal intensive care units (NICU); 

draft guideline for Infection Control in 

Healthcare Personnel; and discussion of 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 200 / Monday, October 18, 2010 / Notices 63845 

infection control in ambulatory care 

settings. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Michelle King, HICPAC, Division of 

Healthcare Quality Promotion, CDC, 

l600 Clifton Road, NE., Mailstop A–07, 

Atlanta, Georgia 30333. Telephone (404) 

639–2936. E-mail: hicpac@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: October 8, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–26113 Filed 10–15–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; ITVA 

Conflicts & Eating Disorders. 

Date: November 10, 2010. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Francois Boller, MD, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6142, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1513, 

bollerf@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Services Conflicts. 

Date: November 12, 2010. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: October 8, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26161 Filed 10–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0389] 

Medical Device User Fees; Public 

Meeting; Extension of Comment Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; extension of comment 

period. 

SUMMARY: The Food and Drug 

Administration (FDA) is extending to 

November 1, 2010, the comment period 

for the notice that appeared in the 

Federal Register of August 13, 2010 (75 

FR 49502). In the notice, FDA requested 

input and comments from interested 

stakeholders on the Agency’s medical 

user fee program and requested 

suggestions regarding the commitments 

FDA should propose for the next 

reauthorized program. The Agency is 

taking this action to allow interested 

persons additional time to submit 

comments. 

DATES: Submit either electronic or 

written comments and information by 

November 1, 2010. 

ADDRESSES: Submit electronic 

comments to http:// 

www.regulations.gov. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. To ensure 

consideration, all comments must be 

received by November 1, 2010. Identify 

comments with the docket number 

found in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

James Swink, Center for Devices and 

Radiological Health, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 66, rm. 1609, Silver Spring, 

MD 20993–0002, 301–796–6313, FAX: 

301–847–8121, e-mail: 

James.Swink@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of August 13, 

2010 (75 FR 49502), FDA published a 

notice announcing a public meeting on 

September 14, 2010, and the opening of 

a public docket to seek input and 

comments from interested stakeholders 

to discuss the Agency’s medical user fee 

program and requested suggestions 

regarding the commitments FDA should 

propose for the next reauthorized 

program. Interested persons were 

invited to submit comments to the 

public docket by October 14, 2010. At 

this time, the Agency is announcing its 

intention to post the transcript of the 

September 14, 2010, public meeting and 

is extending the comment period until 

November 1, 2010, to continue to 

receive public comments. 

II. Request for Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) either electronic or written 

comments regarding this document. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Dated: October 14, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–26253 Filed 10–14–10; 4:15 pm] 

BILLING CODE 4160–01–P 

mstockstill on DSKH9S0YB1PROD with NOTICES